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Abstract
Ichthyosis with confetti (IWC) is a genodermatosis associated with dominant‐nega‐
tive variants in keratin 10 (KRT10) or keratin 1 (KRT1). These frameshift variants result 
in extended aberrant proteins, localized to the nucleus rather than the cytoplasm. 
This mislocalization is thought to occur as a result of the altered carboxy (C)‐termi‐
nus, from poly‐glycine to either a poly‐arginine or ‐alanine tail. Previous studies on 
the type of C‐terminus and subcellular localization of the respective mutant protein 
are divergent. In order to fully elucidate the pathomechanism of IWC, a greater un‐
derstanding is critical. This study aimed to establish the consequences for localiza‐
tion and intermediate filament formation of altered keratin 10 (K10) C‐termini. To 
achieve this, plasmids expressing distinct KRT10 variants were generated. Sequences 
encoded all possible reading frames of the K10 C‐terminus as well as a nonsense 
variant. A keratinocyte line was transfected with these plasmids. Additionally, gene 
editing was utilized to introduce frameshift variants in exon 6 and exon 7 at the en‐
dogenous KRT10 locus. Cellular localization of aberrant K10 was observed via im‐
munofluorescence using various antibodies. In each setting, immunofluorescence 
analysis demonstrated aberrant nuclear localization of K10 featuring an arginine‐
rich C‐terminus. However, this was not observed with K10 featuring an alanine‐rich 
C‐terminus. Instead, the protein displayed cytoplasmic localization, consistent with 
wild‐type and truncated forms of K10. This study demonstrates that, of the various 
3′ frameshift variants of KRT10, exclusively arginine‐rich C‐termini lead to nuclear 
localization of K10.
K E Y W O R D S
alanine‐rich C‐terminus, arginine‐rich C‐terminus, carboxy terminus, ichthyosis with confetti, 
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1  | INTRODUC TION
Ichthyosis with confetti (IWC), also termed congenital reticular 
ichthyosiform erythroderma (CRIE) or ichthyosis variegata (OMIM 
#609165), is a keratinopathy associated with dominant‐negative 
frameshift variants in keratin 10 (KRT10) and keratin 1 (KRT1).1,2 Skin 
of affected patients demonstrates generalized erythroderma, per‐
sisting throughout life. The disease is characterized by the appear‐
ance of numerous patches of pale, healthy‐appearing skin in most 
patients during childhood. These increase in size and number with 
age.3‐5 Currently, 57 patients from 40 families (49% male, 51% fe‐
male) have been reported (Table 1). Of these, 50 were sequenced. 
The majority of these individuals (69%) display a heterozygous vari‐
ant in KRT10 (familial 82%), whereas 31% carry a heterozygous vari‐
ant in KRT1 (familial 18%).
Keratins comprise the components of the epithelial cytoskel‐
eton. Acidic (type I) and basic (type II) keratins heterodimerize 
and subsequently assemble to form intermediate filaments (IFs).6 
Epidermal keratinocytes specifically co‐express keratins as pairs 
in a differentiation‐dependent manner. Keratinocytes of the 
proliferative basal layer express keratin (K) 5 and K14. The dif‐
ferentiating suprabasal epidermal layers are associated with the 
down‐regulation of K5/K14 and expression of thicker K1/K10 fil‐
ament bundles.7
All currently described IWC‐associated variants are deletions, 
insertions or duplications located within the helix‐termination‐motif 
or in the V2 domain of either K10 or K1 (Table 1). Each results in 
frameshifts, leading to the translation of aberrant‐truncated protein 
tails. Nonsense variants in the V2 domain of either K10 or K1 have 
not been reported. Variants leading to −2/+1 frameshifts within re‐
gions encoding the V2 domain are predicted to alter the downstream 
amino acid code from native glycine‐ to arginine‐rich sequences. 
Arginine‐rich sequences frequently function as nuclear localization 
signals.8,9 Therefore, aberrant arginine‐rich K10 or K1 tails might 
be responsible for the pathogenic nuclear localization of K10 or K1, 
characteristic of IWC.
Two studies suggested that alanine‐rich K10 tails might also 
lead to nuclear K10 localization.10,11 In contrast to arginine, ala‐
nine‐rich sequences have not been described to function as nuclear 
localization signal.12 Lim et al,10 suggested that a KRT10 frameshift 
variant at the exon 6/intron 6 boundary resulted in an alanine‐rich 
tail. However, the original c.1373delG nomenclature for this variant 
should rather be annotated as c.1373+1delG, according to the se‐
quence variant nomenclature HGVS,13 indicating a splice site vari‐
ant. Variants of this nature often lead to the expression of multiple 
splicing products. Full examination of the expression products of 
this variant is therefore justified. The presence of additional K10 
splicing products, featuring arginine‐rich tails, may explain the nu‐
clear K10 localization displayed in the epidermis of this patient. Hotz 
et al11 also suggested that an IWC‐associated variant (c.1544delG) 
resulted in an alanine‐rich K10 tail. However, the variant was later 
on corrected to c.1544dupG and has been suggested to result in an 
arginine‐rich K10 tail.14
In support of a non‐nuclear localizing signal of alanine‐rich kera‐
tin tails, frameshift variants in KRT1, leading to alanine‐rich tails, are 
reported to cause ichthyosis hystrix Curth‐Macklin (IHCM)15,16 and 
striate palmoplantar keratoderma (SPPK).17 Keratinocytes of these 
patients do not display nuclear localization of aberrant K1 products.16
The aim of this study was to clarify the effects of mutant K10 
tail variants on the pathogenic nuclear localization of the protein. 
In order to elucidate this, we established two distinct cell culture 
models. The first model (transgenic model) centred on the tran‐
sient expression of N‐terminal eGFP‐labelled K10 cDNA or gDNA, 
featuring mutant K10 tail variations, in an immortalized wild‐type 
human keratinocyte line (NKc21). This model enabled determination 
of the subcellular localization of K10 translated from IWC‐associ‐
ated alleles. In vivo, the effects of KRT10 variants are not observ‐
able in undifferentiated keratinocytes. Endogenous regulation of 
KRT10 expression ensures equal ratios of mutant and wild‐type K10. 
Therefore, a context more closely resembling the in vivo situation 
enabled better analysis of the effect of IWC‐associated alleles. This 
was achieved through the second model (endogenous model), gener‐
ated via CRISPR/Cas9‐mediated gene editing, which featured these 
variants at the endogenous KRT10 locus in NKc21 keratinocytes.
This study elucidates the relationship between K10 C‐termini 
variants and K10 nuclear localization. The influence of C‐termini 
variants on keratinocyte differentiation, K10 polymerization with 
assembly partners and the intracellular localization of these poly‐
mers were additionally characterized.
2  | MATERIAL AND METHODS
2.1 | Plasmids and transfection
cDNA‐derived KRT10 was PCR‐generated from epidermal mRNA iso‐
lated from an IWC patient3 (p5_arg_c_GFP) or a healthy control (p2_
wt_c_GFP). This was cloned into XhoI and HindIII sites of the pEGFP‐C1 
vector (Clontech Laboratories Inc Takara). Sequences encoding the ala‐
nine‐rich C‐terminus (p10_ala_c_GFP) or a premature stop (p13_ter_c_
GFP) were inserted into p2_wt_c_GFP via site‐directed mutagenesis 
(GenScript®). Genomic DNA‐derived KRT10 from a healthy control was 
cloned into pUC19 in two steps following amplification of KRT10 as 3′ 
and 5′ products. Initially, intron 5 to 3′‐UTR gDNA was inserted into 
the HincII and HindIII restriction sites of pUC19 (pUC_K10‐ex5‐3′). 
Subsequently, the 5′ product (mid of exon 1 to exon 4) was introduced 
into the SacI and HincII restriction sites of pUC_K10‐ex5‐3′. This com‐
bined product (pUC‐K10) was inserted into the SacI and HindIII restric‐
tion sites of p2_wt_c_GFP, exchanging cDNA between mid of exon 1 
to 3′‐UTR for a complete gDNA sequence. This wild‐type gDNA con‐
struct (p1_wt_g_GFP) contained a common 12 bp deletion in exon 7 
(rs778613907)5 enabling it to be distinguished from endogenous KRT10 
of NKc21. The IWC100 variant10 (c.1373+1delG) (p4_var_g_GFP) was in‐
serted via site‐directed mutagenesis (GenScript®). Subconfluent NKc21 
keratinocytes were transfected with p1_wt_g_GFP or p4_var_g_GFP to 
receive the differentially spliced KRT10 mRNA. After full‐length PCR 
and separation on 1% agarose gel, they were cloned into pEGFP‐C1 
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Type of variant ReferenceMale Female KRT1 KRT10
1* 1 1  1    Unknown 4
1* 1  1 1    Unknown 30
1* 1 1  1    Unknown 31
1* 1  1 1    Unknown 32
1* 1  1 1    Unknown 33
1* 1 1  1    Unknown 34
6 6 3 3 6      
1 1  1 1   c.1370G>T†  Exon 6 1,35
1 1 1  1   c.1373+1delG††  Donor splice site 10
3 1 2 1    c.1373+1G>A Donor splice site 1
3 1 1 2 3 2  c.1373+1G>C Donor splice site 14
1 1 1  1   c.1373+2T>C Donor splice site 14
1 1  1    c.1374‐2delA Acceptor splice site 1
1 1 1  1 1  c.1374‐2A>C Acceptor splice site 36
2 2 2  1   c.1374‐2A>G Acceptor splice site 1,37
4 3 1 2 2   c.1374‐1G>A Acceptor splice site 1,5,38
5 5 3 3 6 1  c.1374‐1G>C Acceptor splice site 5,14,39‐41
1 1  1 1   c.1383_1414del Exon 7 39
1 1  1 1   c.1411_1412insA Exon 7 14
1 1 1     c.1449_1450insC Exon 7 1
1 1 1  1   c.1452_1464delinsAG Exon 7 42
1 1  1 1   c.1506_1507del Exon 7 4,5,43,44
2 2  2 2   c.1544dupG‡  Exon 7 11,14
1 1  1 1   c.1546_1551delinsT Exon 7 3,5,45
1 1  1 1   c.1557_1558delCG Exon 7 5
2 1 1 1    c.1560_1561delGC Exon 7 1
2 1  2 1   c.1573dupA Exon 7 5
35 (69%) 28 (82%) 15 20 25 4  20 43% exonic, 57% 
splice site (families)
 
6 1 2 4 5 3a c.591+329_1129‐
37del
 Exon 9 46
1 1 1  1 1b c.1756_1757insG†††  Exon 9 47
1 1 1  1 1b c.1752dupT  Exon 9 14
3 1 1 2 3 1 c.1758_1759insT  Exon 9 48
1 1 1  1 1c c.1860_1861insT  Exon 9 49
4 1 4  4  c.1865_1866insG  Exon 9 2
16 (31%) 6 (18%) 10 6 15 7 6  100% exonic  
Note: All IWC patients carry heterozygous variants in KRT10 (NM_000421) or KRT1 (NM_006121). Two variants, originally described as a poly‐ala‐
nine reading frame, have been redefined according to HGVS nomenclature (indicated by †† and ‡). Six patients, which have not been sequenced but 
displayed typical IWC clinical features, including pale spots, are also listed (indicated by *). Data include eleven patients from different families who 
have not currently developed pale spots but carry a poly‐arginine tail‐causing frameshift variant. Of these, three siblings in a familial IWC resembled 
epidermolytic ichthyosis (EI) (indicated by a). Three sporadic cases were clinically described as EI (indicated by b) or ichthyosis hystrix Curth‐Macklin 
(IHCM) (indicated by c).
aResembled epidermolytic ichthyosis (EI). 
bDescribed as epidermolytic hyperkeratosis, renamed as epidermolytic ichthyosis (EI) (OMIM #113800). 
cDescribed as ichthyosis hystrix Curth‐Macklin (OMIM #146590). 
†Originally described as c.1369G>T; results in a new donor splice site. 
††Originally described as c.1373delG (alanine‐rich C‐terminus). 
†††Originally described as c.1751insG. 
‡One of them initially described as c.1544delG (alanine‐rich C‐terminus). 
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using XhoI and HindIII restriction sites (Figure 1A). To distinguish the 
KRT10wt, KRT10arg and KRT10ala products following combined transfec‐
tion in cell imaging analyses, eGFP in p6_arg_s_GFP and p11_ala_s_GFP 
was replaced with mCherry. Constructs are summarized in Table S1 and 
Figure S1. NKc21 keratinocytes were transfected with Xfect transfec‐
tion reagent (Takara Bio Europe) as previously described.18 Transfected 
cells were seeded on coverslips 48 hours post‐treatment and subse‐
quently fixed 24 hours later with 4% formaldehyde. Transfection rates 
were approximately 30%.
2.2 | Cell culture
Keratinocyte line NKc21 (kindly provided by Hans Törmä)19 was 
grown in CnT‐PR (CELLnTEC). Cells were cultured in a humid atmos‐
phere at 37°C and 5% CO2. Integrity of cells and chromosomes was 
validated by SNP array (Illumina, HumanOmniExpressExome‐8v1‐3).
Mouse 3T3‐J2 fibroblasts (ATCC) were grown in DMEM (Lonza) 
supplemented with antibiotic‐antimycotic and 10% foetal calf serum 
(ThermoFisher Scientific Inc). Feeder cells were generated from this 
cell line following mitomycin C (StressMarq Biosciences) treatment 
(4 mg/mL for 2 hours). These were subsequently used in keratino‐
cyte single‐cell cloning.
2.3 | CRISPR‐Cas9‐mediated gene editing and 
single‐cell cloning
Plasmid pSpCas9(BB)‐2A‐GFP (PX458) (kindly gifted from Feng 
Zhang, Addgene plasmid #48138) was used for generation of 
GFP‐labelled Cas9 vectors.20 In brief, the sgRNA oligos were li‐
gated into pSpCas9(BB)‐2A‐GFP after digestion with restriction 
enzyme BbsI. These resulted vectors carried either guide RNA 
cr26 (GGCGGCGGAAGTTTCGGCGG, KRT10, exon 7) or cr33 
(GCCTGCTAGAAGGAGAGGGA KRT10, exon 6). Plasmids were 
transfected with Xfect polymer (Takara Bio) as previously de‐
scribed.18 Briefly, 70 000 keratinocytes per well were seeded in 
6‐well plates. One day later, a mixture of 660 ng of CRISPR/Cas9 
plasmid, 0.2 µL Xfect polymer and 100 µL Xfect buffer was incu‐
bated at room temperature for 10 minutes and added to the keratino‐
cytes. After 4 hours at 37°C, the medium was exchanged. Individual 
GFP‐fluorescent cells were FACSorted 72 hours later on an Aria II 
cell sorter (BD Biosciences) using 100 µm nozzle and 15 psi pres‐
sure. They were co‐cultivated with mouse 3T3‐J2 feeder fibroblasts 
(ATCC)21 previously arrested with 4 g L−1 mitomycin C (StressMarq 
Biosciences) in 96‐well plates. Clones were subsequently expanded. 
Corresponding sequence data on KRT10 are summarized in Table S2.
2.4 | Keratinocyte differentiation and epidermal 
equivalent formation
Since KRT10 is only expressed in differentiated cells, differentiation 
was induced in confluent cultures in the absence of growth factors 
and at high calcium concentration (1.2 mM). For mRNA isolation, ke‐
ratinocytes were cultured in CnT‐PR medium (CELLnTEC). One day 
before expected confluency, medium was exchanged to CnT‐PR‐D 
(CELLnTEC). At confluency, CaCl2 (Vitaris) was added to a final concen‐
tration of 1.2 mM. RNA was isolated 72 hours after addition of calcium.
For cellular localization of K10, clonal keratinocyte cultures were 
seeded onto 0.4 µm PCF Millicell cell culture inserts (Merck Millipore®) 
and cultivated in CnT‐PR medium. After 3 days, cells reached conflu‐
ency and the medium was exchanged with CnT‐PR‐3D (CELLnTEC to 
promote differentiation. The following day, medium inside the insert 
was removed. Medium outside the insert was changed three times a 
week. Two weeks after the start of differentiation, epidermal models 
were formalin‐fixed and paraffin‐embedded (FFPE) for subsequent 
haematoxylin and eosin staining. Each frameshift mutation was anal‐
ysed with two distinct clones. For K10arg six differentiated clones (2x 
e3_arg_26‐1, 4x e4_arg_26‐1) and for K10ala nine differentiated clones 
(6x e5_ala_26‐1, 3x e6_ala_26‐1) were examined.
For quantitation of epidermal thickness, the thickness of kerati‐
nocyte layers and insert membrane was measured on haematoxylin‐ 
and eosin‐stained epidermal equivalents. For K10arg six differentiated 
clones (2x e3_arg_26‐1, 4x e4_arg_26‐1) and for K10ala seven dif‐
ferentiated clones (4x e5_ala_26‐1, 3x e6_ala_26‐1) were examined. 
ANOVA tests were used for statistical analysis.
2.5 | Sequencing of gDNA and RNA
Genomic DNA and mRNA were isolated from confluent keratino‐
cyte cultures 48 hours post‐transfection according to the manu‐
facturer's protocol (NucleoSpin® Tissue and NucleoSpin® RNA XS, 
Macherey‐Nagel). cDNA was synthesized (Verso cDNA Synthesis 
kit, ThermoFisher Scientific Inc) and amplified by PCR with KRT10‐
specific primers (Taq DNA or HotStar HiFidelity polymerase, Qiagen) 
(Table S3). Sanger sequencing was performed by an external vendor 
(Microsynth AG).
2.6 | Ratio of mRNA p9_arg_s_GFP and p11_ala_s_
GFP
AB 3130 Genetic Analyzer was used to determine the ratio of 
KRT10arg (p9_arg_s_GFP) and KRT10ala (p11_ala_s_GFP) mRNA 
within PCR products (Figure 1) by fragment analysis as previ‐
ously described.22 In brief, PCR was performed on cDNA follow‐
ing p4_var_g_GFP transfection with one FAM‐labelled primer. This 
was stopped after 30 cycles to stay in the log phase of amplifi‐
cation. GeneScan™ 500 ROX™ (ThermoFisher Scientific Inc) was 
used as size standard. Quantitative assessment of PCR product 
was achieved following calculation of areas under the curve using 
GeneMapper.
2.7 | Immunofluorescence staining
Immunofluorescence staining was performed as previously de‐
scribed both on keratinocytes containing the respective plasmid 
grown on coverslips and on formalin‐fixed and paraffin‐embedded 
(FFPE‐slides) keratinocytes of the epidermal models.3
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In brief, samples were blocked in donkey serum and tri‐
ton‐X‐100 in TBS for 1 hour and incubated with primary antibod‐
ies either at RT for 1 hour (coverslips) or at 4°C overnight (slides). 
After washing, secondary antibody and DAPI for nuclear staining 
(Sigma‐Aldrich) were incubated at RT for 1 hour. After additional 
washing steps, samples were mounted with ProLong™ Diamond 
Antifade Mountant (ThermoFisher Scientific Inc). The following 
primary antibodies were used: mouse monoclonal antibodies to 
the N‐terminus of K10 DE‐K10 (Abcam) and LH2 (kindly gifted by 
Irene Leigh, Dundee, UK, and Andrew South, Philadelphia, USA), 
rabbit monoclonal antibodies to the carboxy terminus of K10 SP99 
and EP1607IHCY (both Abcam) (Table S4). Additional primary an‐
tibodies were goat polyclonal to GFP (Abcam), rabbit polyclonal 
to K5 (Biolegend) and monoclonal to K14 (EP1612Y, Abcam) as 
well as polyclonal rabbit to lamin B1 and fibrillarin (both Abcam). 
Conjugated secondary donkey antibodies originated from Jackson 
ImmunoResearch and ThermoFisher Scientific Inc Fluorescent sig‐
nals were imaged under a Zeiss confocal microscope LSM710 with 
a Zeiss 40x/1.3 and 63x/1.4 objective.
3  | RESULTS
3.1 | IWC‐associated KRT10 variants result in an 
arginine‐rich C‐terminus
NKc21 keratinocytes were transfected with KRT10 gDNA con‐
structs, featuring either wild‐type (p1_wt_g_GFP) or a previously 
described IWC‐associated splice site variant (p4_var_g_GFP)10 
to investigate the presence and composition of potential addi‐
tional splice products (Table S1). The wild‐type construct resulted 
in the transcription of one main mRNA product of the expected 
size (2.1 kb) (wt_s). In contrast, the construct encoding the IWC‐
causing sequence resulted in four major mRNA products, of dif‐
fering sizes (Figure 1A). Each mRNA was distinct (Table S1, Figure 
S1). Subcloning and sequencing of these products demonstrated 
deletions of complete exons (r.1156_1373del; subcloned in p6_
arg_s_GFP) (r.1030_1373del; subcloned in p8_arg_s_GFP), both 
would lead to the expression of K10arg (p.Lys386PhefsTer118 
and p.Ser344PhefsTer118). The third product (subcloned in 
F I G U R E  1   Products amplified from 
total KRT10 mRNA of NKc21 cells after 
transfection with either wild‐type or IWC‐
associated KRT10 gDNA. A. PCR‐amplified 
cDNA product, following transfection 
of NKc21 cells with wild‐type plasmid 
(p1_wt_g_GFP), was at the expected 
wild‐type size (~2.1 kb). Transfection with 
IWC‐associated KRT10 gDNA (p4_var_g_
GFP) resulted in four major products, of 
distinct sizes (~2.4, ~2.1, ~1.9 and ~1.8 kb). 
Each product was cloned into pEGFP‐
C1 for further studies. B. Unsaturated 
PCR following RT‐PCR of transcripts 
after transfection with p4_var_g_GFP, 
using primers localized in exon 6 and 7. 
These only amplify the 2.1 kb products. 
Separation of the resulting products 
(3130xl Genetic Analyzer, Applied 
Biosystems) showed peaks at 272 bp 
(arg_s) and 276 bp (ala_s). Measurement of 
the area under the curve (ht) revealed the 
quantity of PCR product, almost double 
the amount of the 4 bp shorter KRT10arg 
(arg_s, r.1369_1373del) vs. KRT10ala (ala_s, 
r.1373del) PCR product. Red triangles 
indicate the size marker (GeneScan™ 500 
ROX™ (ThermoFisher Scientific Inc))
A
B
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p14_ter_s_GFP) contained the complete intron 6, resulting in a 
shifted reading frame with a stop codon after 4 bp of intron 6. 
The fourth product contained two sequences, with the major‐
ity of products displaying a 5 bp deletion of the 3′‐terminus of 
exon 6 (r.1369_1373del, p.Gly457PhefsTer118; subcloned in p9_
arg_s_GFP) leading to K10arg expression. A minority of products 
displayed a deletion of the last nucleotide of exon 6 (r.1373del; sub‐
cloned in p11_ala_s_GFP), encoding K10ala (p.Ser458IlefsTer157). 
Quantitative assessment of an unsaturated PCR enabled relative 
PCR quantification and revealed 66% KRT10arg (p9_arg_s_GFP) and 
33% KRT10ala (p11_ala_s_GFP) products (Figure 1B).
In summary, the majority of identified mRNAs resulting from 
p4_var_g_GFP encoded an aberrant K10arg (p6_arg_s_GFP, p8_
arg_s_GFP, p9_arg_s_GFP). The remainder encoded either K10ter 
(p14_ter_s_GFP) or K10ala (p11_ala_s_GFP). This indicates that a 
change in the donor splice site of intron 6, due to the 1 bp deletion, 
results in alternative splicing and frequently arginine‐rich C‐termini. 
Alternative splicing is supported by splice site prediction tools such 
as BDGP (0.93 → below cut‐off 0.40; http://www.fruit fly.org/seq_
tools/ splice.html), NetGene2 (0.93 → 0.71; http://www.cbs.dtu.dk/
servi ces/NetGe ne2/) and SplicePort (1.06 → not recognized; http://
splic eport.cbcb.umd.edu/). These suggested a reduced confidence 
for the recognition of the mutated splice site compared with the 
wild‐type sequence.
3.2 | Nuclear translocation of K10 is initiated by an 
arginine‐rich C‐terminus
The consequence of IWC‐associated KRT10 variants on cellular lo‐
calization was initially analysed in vitro. Plasmids encoding eGFP‐
labelled KRT10 cDNA were generated. These carried previously 
reported IWC‐associated frameshift variants described to result 
in each alternate reading frame (−2/+1 or −1/+2).3,11,14 Transient 
expression in keratinocytes resulted in arginine‐ (K10arg) and 
alanine‐rich (K10ala) K10 products, respectively. Additionally, 
keratinocytes transiently expressing a cDNA featuring a hypo‐
thetical nonsense variant localized to the region encoding the 
V2 domain of K103,11 were analysed. This resulted in the expres‐
sion of a C‐terminal‐truncated K10 (K10ter). Alternatively, the 
plasmids carried a splice product expressed by NKc21 cells after 
transfection with p4_var_g_GFP (Table S1). Plasmids expressing 
these eGFP‐tagged KRT10 cDNA variants (p2_wt_c_GFP, p5_
arg_c_GFP, p10_ala_c_GFP, p13_ter_c_GFP) in addition to gDNA 
(p1_wt_g_GFP, p4_var_g_GFP) and previously subcloned splice 
products (p3_wt_s_GFP, p6_arg_s_GFP, p8_arg_s_GFP, p9_arg_s_
GFP, p11_ala_s_GFP, p14_ter_s_GFP) were transiently trans‐
fected into NKc21 cells. This enabled analysis of the subcellular 
localization of each aberrant K10 product. Wild‐type K10 (K10wt) 
encoded by p1_wt_g_GFP, p2_wt_c_GFP and p3_wt_s_GFP was 
exclusively observed in the cytoplasm. Here, it was organized into 
filament structures (Figure 2). K10arg from patient‐derived cDNA 
(p5_arg_c_GFP), K10arg‐expressing plasmids (p6_arg_s_GFP, p9_
arg_s_GFP) and products translated from IWC‐related sequence 
(p4_var_g_GFP) displayed nuclear localization (Figure 3). K10ala 
(p10_ala_c_GFP, p11_ala_s_GFP) and truncated K10ter (p13_ter_c_
GFP, p14_ter_s_GFP) were exclusively localized to the cytoplasm 
(Figure 4). As expected, aberrant K10 could not be detected via 
C‐terminus‐specific antibodies (EP1607IHCY, SP99) (Figure S2).
Co‐transfection with combinations of distinct fluorescence‐la‐
belled KRT10arg and KRT10ala (p6_arg_s_GFP/p12_ala_s_mCherry 
or p7_arg_s_mCherry/p11_ala_s_GFP) resulted in an expected nu‐
clear signal of K10arg. However, the unexpected nuclear localization 
of K10ala was also observed (Figure S3). Co‐transfection with dis‐
tinct fluorescence‐labelled K10arg (p7_arg_s_mCherry) and K10wt 
(p3_wt_s_GFP) resulted in nuclear‐localized eGFP. This indicated 
co‐translocation of K10wt with K10arg into the nucleus. Further, it 
may suggest the nuclear translocation of higher keratin polymers 
(Figure S3).
Immunostaining of cellular K5 and K14 after NKc21 transfection 
with a K10arg vector (p5_arg_c_GFP) revealed a nuclear signal for 
endogenous K5 in approximately 30% of all transfected cells (Figure 
S4). K5 is a type II keratin, a promiscuous assembly partner of the 
type I K10. The apparent nuclear signal of K5 suggests the co‐trans‐
port of keratin dimers. A nuclear K14 signal was not detectable (data 
not shown).
Our results indicate that exclusively aberrant K10arg is translo‐
cated to the nucleus. Furthermore, they suggest that aberrant K10arg 
can pull other keratins (ie K10wt, K10ala and K5), which do not feature 
an arginine‐rich C‐terminus, into the nucleus. This likely occurs as 
keratin dimers and tetramers.
3.3 | Endogenous expression of aberrant K10 leads 
to abnormal differentiation of keratinocytes in culture
Keratinocyte clones were generated via CRISPR/Cas9‐mediated 
gene editing enabling the introduction of heterozygous −2/+1 
(KRT10arg) or −1/+2 (KRT10ala) frameshifts into regions encoding 
the V2 domain. As a result, variants similar to those found in IWC 
patients were generated in NKc21 keratinocytes. This enabled the 
analysis of aberrant K10 subcellular localization in an endogenous 
setting. Six clones with heterozygous frameshift variants were stud‐
ied. Four displayed expression K10arg (e1_arg_33‐1, e2_arg_33‐1, 
e3_arg_26‐1, e4_arg_26‐1), and two demonstrated expression 
K10ala (e5_ala_26‐1, e6_ala_26‐1) (Table S2). Sequencing of cDNA 
derived from differentiated cells confirmed transcription of the ex‐
pected KRT10 mRNAs (Table S2).
Epidermal equivalents derived from K10arg single‐cell clones 
were subjected to haematoxylin and eosin (HE) staining. These dis‐
played stratified epithelium including: basal layer, differentiated 
suprabasal layers and stratum corneum comparable to wild‐type 
and mock controls (Figure 5A‐C). However, epidermal equivalents 
derived from K10ala clones displayed an epithelium with strongly 
impaired differentiation and significantly thinner than epidermal 
equivalents from K10arg and K10wt (Figure 5D, Figure S5).
Immunofluorescence analysis of differentiated keratinocytes 
via either N‐ or C‐terminus‐specific anti‐K10 antibodies indicated 
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a nuclear localization of K10 signal in K10arg keratinocytes. K10ala‐
differentiated keratinocytes displayed cytoplasmic signals alone, 
comparable to K10wt (Figure 6). Immunostaining via the C‐termi‐
nus‐specific K10 antibody enabled exclusive staining of K10wt. 
This revealed nuclear localization of K10wt in the differentiated 
suprabasal layers of epidermal equivalents derived from hetero‐
zygous K10arg keratinocyte single‐cell clones. Similar observations 
were noted following co‐immunostaining for K5. This supports our 
conclusion that, minimally, keratin tetramers driven by K10arg are 
subjected to nuclear co‐localization (Figure S6). Additionally, lamin 
B1 displayed reduced expression in K10ala expressing keratino‐
cytes. This may indicate a disturbed nuclear integrity in affected 
keratinocytes.
4  | DISCUSSION
In keratinocytes derived from IWC patients, K10 displays nuclear 
localization, correlated with −2/+1 frameshift variants (K10arg). 
However, the effect of K10ala was previously inconclusive. 
Approximately 70% of IWC patients carry KRT10 frameshift variants. 
These affect splice sites in 60% of cases. Of the currently reported 
IWC‐associated KRT10 splice site variants, approximately 30% af‐
fect the donor splice site of intron 6. Analysis of mRNA from pa‐
tients with IWC‐associated splice site variants revealed transcripts 
that would be translated into K10 with arginine‐rich tails.1 Lim et 
al10 described a K10 splice site variant, comprised of a 1 bp dele‐
tion at the exon‐intron boundary of exon 6/IVS6. They suggested 
that this variant resulted in K10ala expression, without experimental 
confirmation.10 In the present study, we demonstrated that this vari‐
ant leads to several alternative splicing products. In contrast to prior 
suggestions, the majority of these products are predicted to result 
in K10arg expression.
C‐terminal frameshift variants in KRT10 remain poorly investi‐
gated in a systematic manner. Therefore, little is understood regard‐
ing the effects of IWC‐associated variants on the cellular localization 
of K10. Our studies provide the first systematic analysis on nuclear 
K10 localization in IWC. Three possible C‐terminal frames of KRT10 
were analysed in addition to a speculative nonsense variant. Our 
data clearly indicate that only K10arg translocates to the nucleus, 
whereas K10wt, K10ala and K10ter remain in the cytoplasm. However, 
the presence of K10arg enables the co‐translocation of non‐K10arg 
into the nucleus.
These results contradict a previous suggestion that K10ala may 
cause pathogenicity in an IWC patient with a splice site variant.10 
However, sequencing of the corresponding cDNA was not previ‐
ously performed to confirm a frameshift at the level of transcrip‐
tion. Human splice sites are highly conserved; >99.9% are canonical 
(donor site: GT, GC, AT).23 Further, exonic sequences close to the 
exon‐intron boundaries are highly conserved. The 3′‐most exonic 
nucleotide is a guanine in over 80% of instances.24‐26 Analysis of 
splicing products from gDNA harbouring this variant revealed five 
transcripts. Three of these encoded K10arg, one encoded K10ter, and 
a minor transcript encoded K10ala at the limit of detection. The pres‐
ence of these transcript varieties concurs with splice site prediction 
tools. However, a similar in vivo splicing profile could only be con‐
firmed in patient epidermal biopsies.
In addition to the patient described by Lim et al,10 three families 
reportedly carry similar variants with exchanges in the splice site 
sequence (c.1373+1G>A; c.1373+1G>C; c.1373+2T>C).1,11 mRNA 
isolated from a patient carrying the c.1373+1G>A variant displayed 
a full deletion of exon 6,1 a product identical to a major splice prod‐
uct that we observed (p6_arg_s). This patient data support our 
findings that splicing of this mutant mRNA frequently causes de‐
letion of exon 6. This results in frameshift and consequently K10arg 
expression.
F I G U R E  2   Localization of K10 
following transient transfection of NKc21 
keratinocytes with K10wt encoding 
plasmids. K10 was detected either by 
imaging the eGFP fluorescence expressed 
from plasmid (cellular eGFP, green) or 
immunostaining with anti‐K10 antibody 
DE‐K10 (orange). The nuclear membrane 
was labelled with an anti‐lamin antibody 
(red). DAPI (blue) was used for nuclear 
staining. All K10 constructs: KRT10 
wild‐type gDNA (p1_wt_g_GFP), the 
corresponding cDNA (p3_wt_s_GFP) or 
cDNA from a wild‐type control (p2_wt_c_
GFP) carried an N‐terminal eGFP‐tag. 
Antibodies against K10 and lamin showed 
clear cytoplasmic localization in every 
wild‐type K10. Scale bar, 5 μm
     |  8449RENZ Et al.
In K10ala, altered C‐terminal amino acids result in the loss of 
neutral glycine loops in favour of neutral alanine sequences. Basic 
amino acids, associated with classical nuclear localization se‐
quences, are not present.27 As a result, K10ala is not expected to 
display an altered subcellular localization. In contrast, the basic 
amino acid arginine is assumed to change the pK‐value of the 
C‐terminus of K10arg and subsequently the recognition signal for 
nuclear targeting.28
The endogenous model, described in the present study, sup‐
ported a cytoplasmic localization of K10ala. Epidermal equiva‐
lents grown from keratinocytes expressing K10ala demonstrated 
significantly impaired stratification. In contrast to K1, in which 
F I G U R E  3   Localization of K10 
following transient transfection of NKc21 
keratinocytes with K10arg encoding 
plasmids. K10 was detected either by 
imaging of eGFP expressed from plasmid 
(cellular eGFP, green) or immunostaining 
with an anti‐K10 antibody (DE‐K10, 
orange). The nuclear membrane was 
labelled with an anti‐lamin antibody (red). 
DAPI (blue) was used for nuclear staining. 
All K10 constructs: IWC‐causing KRT10 
gDNA (p4_var_g_GFP), the corresponding 
cDNA from splice products (p6_arg_s_
GFP, p9_arg_s_GFP) and patient cDNA 
(p5_arg_c_GFP) carried an N‐terminal 
eGFP‐tag. The expressed K10 was 
localized in the nucleus of transfected 
keratinocytes. Scale bar, 5 μm
F I G U R E  4   Localization of K10 
following transient transfection of NKc21 
keratinocytes with K10ala‐ or K10ter‐
encoding plasmids. K10 was detected 
either by imaging of eGFP expressed 
from plasmid (cellular EGFP, green) or 
immunostaining with an anti‐K10 (DE‐
K10) or anti‐GFP antibody (both orange). 
The nuclear membrane was labelled 
with an anti‐lamin antibody (red). DAPI 
(blue) was used for nuclear staining. All 
K10ala (p10_ala_c_GFP, p11_ala_s_GFP) 
or K10ter (p13_ter_c_GFP, p14_ter_s_GFP) 
carried an N‐terminal EGFP‐tag. K10arg 
and K10ter were both exclusively localized 
in the cytoplasm. As the aberrant K10 
in p11_ala_s_GFP and p14_ter_s_GFP 
could not be detected with the DE‐K10 
antibody, the anti‐GFP antibody was used 
for staining. Scale bar, 5 μm
8450  |     RENZ Et al.
F I G U R E  5   Epidermal equivalents 
derived from gene edited NKc21 single‐
cell clones expressing K10ala displayed 
thin epithelium. Haematoxylin and eosin 
staining of epidermal models. Epidermal 
equivalents derived from wild‐type (A), 
mock control (B), and heterozygous K10arg 
clones (C) displayed a differentiated 
epithelium including basal layer and 
stratum spinosum (orange bar). Epidermal 
equivalents derived from K10ala clones 
demonstrated a thin epithelium (D). All 
shown clones were cultivated in parallel, 
epidermal equivalents C and D are derived 
from clones e4_arg_26‐1 (K10arg) and 
e6_ala_26‐1 (K10ala). Parakeratosis was 
observed in all samples (black arrows). The 
supporting filter membrane is indicated 




F I G U R E  6   Epidermal equivalents derived from K10arg keratinocyte single‐cell clones display nuclear localization of K10 in differentiated 
suprabasal layers. Immunofluorescence staining via N‐ (LH2, exact binding region unknown; red) and C‐terminus‐specific (EP1607IHCY, 
amino acids 555‐584; green) K10 antibodies indicated nuclear localization of K10 in the suprabasal keratinocytes of K10arg‐derived 
equivalents (white arrowhead). In K10wt‐ or K10ala‐derived equivalents, K10 was localized exclusively in the cytoplasm. Nuclear co‐
translocation of endogenous K10wt and K10arg (e4_arg_26‐1) enabled observation of nuclear localization via the C‐terminus‐specific anti‐
K10 (white arrowhead). DAPI (blue) was used for nuclear staining. Border between supporting filter membrane and basal layer indicated 
(white‐dotted line). Scale bar, 20 μm
     |  8451RENZ Et al.
an alanine‐rich C‐terminus results in the severe phenotype of 
IHCM15,16,29 or SPPK,17 no patients have been described with 
K10ala‐associated variants. This is in line with our data of an im‐
paired differentiation in K10ala keratinocytes, which might result in 
lethality.
Keratins promiscuously form heterodimers consisting of 
equimolar amounts of type I and type II keratins.6 These subse‐
quently polymerize to form keratin IFs. K1 is present within the 
nucleus of K10arg‐positive keratinocytes of IWC patients.
1 This 
is likely co‐translocated with K10arg in the form of dimers. In line 
with this observation, we observed nuclear co‐localization of K5 
with K10arg in our model systems. This has also been observed in 
patient keratinocytes (unpublished data). Further, we observed 
nuclear co‐localization of K10arg/K10wt in addition to K10arg/
K10ala. This may be a result of K10arg‐containing tetramers or 
higher‐order polymers passing the nuclear membrane. However, 
K14 was unexpectedly not detectable in the nuclear keratin com‐
plexes, possibly a result of poor epitope recognition by the mono‐
clonal antibody.
In summary, this study provides a deeper understanding of the 
nuclear localization of aberrant K10 in IWC which is correlated to 
a single altered reading frame in K10. We confirmed that arginine‐
rich K10 tails, and not alanine‐rich K10 tails, are responsible for the 
pathogenic nuclear localization of K10 in affected patients. A greater 
understanding of keratin nuclear localization in IWC advances the 
potential use of the subsequent mechanism of chromosomal ex‐
change for natural gene therapies.
ACKNOWLEDG EMENTS
We thank Hans Törmä (Uppsala, Sweden) for providing the NKc21 
cell line and Irene Leigh and Andrew South for providing the anti‐
body LH2. We are grateful to our Pathology Department for em‐
bedding the epidermal equivalents and Nicholas Sanderson (Basel, 
Switzerland) for support in cloning. We also thank our microscope 
and FACS facilities for support. The study was ethically approved 
by the local ethics committee (Ethikkommission Nordwest‐ und 
Zentralschweiz) (EK203/13) and financially supported by Louis 
Widmer Fonds (Schlieren, Switzerland).
CONFLIC T OF INTERE S T
Nothing to disclose.
AUTHOR CONTRIBUTIONS
PR, EI, IS, HW and SvA performed the experiments. MA, OPM and 
AV contributed essential tools. PR, AV and BB analysed the data. BB, 
JR and OPM wrote the paper. PHI, JR and BB designed the study.
DATA AVAIL ABILIT Y S TATEMENT
I am willing to share my research data.
ORCID
Bettina Burger  https://orcid.org/0000‐0002‐7686‐0176 
R E FE R E N C E S
 1. Choate KA, Lu Y, Zhou J, et al. Mitotic recombination in patients 
with ichthyosis causes reversion of dominant mutations in KRT10. 
Science. 2010;330(6000):94‐97.
 2. Choate KA, Lu Y, Zhou J, et al. Frequent somatic reversion 
of KRT1 mutations in ichthyosis with confetti. J Clin Invest. 
2015;125:1703‐1707.
 3. Burger B, Spoerri I, Schubert M, et al. Description of the natural 
course and clinical manifestations of ichthyosis with confetti caused 
by a novel KRT10 mutation. Br J Dermatol. 2012;166:434‐439.
 4. Camenzind M, Harms M, Chavaz P, Saurat JH. [Confetti ichthyosis]. 
Ann Dermatol Venereol. 1984;111:675‐676.
 5. Spoerri I, Brena M, De Mesmaeker J, et al. The phenotypic and ge‐
notypic spectra of ichthyosis with confetti plus novel genetic vari‐
ation in the 3′ end of KRT10: from disease to a syndrome. JAMA 
Dermatol. 2015;151:64‐69.
 6. Hatzfeld M, Franke WW. Pair formation and promiscuity of cytoker‐
atins: formation in vitro of heterotypic complexes and intermediate‐
sized filaments by homologous and heterologous recombinations 
of purified polypeptides. J Cell Biol. 1985;101:1826‐1841.
 7. Reichelt J, Bussow H, Grund C, Magin TM. Formation of a normal 
epidermis supported by increased stability of keratins 5 and 14 in 
keratin 10 null mice. Mol Biol Cell. 2001;12:1557‐1568.
 8. Christie M, Chang CW, Rona G, et al. Structural biology and 
regulation of protein import into the nucleus. J Mol Biol. 
2016;428:2060‐2090.
 9. Melen K, Kinnunen L, Julkunen I. Arginine/lysine‐rich structural el‐
ement is involved in interferon‐induced nuclear import of STATs. J 
Biol Chem. 2001;276:16447‐16455.
 10. Lim YH, Qiu J, Saraceni C, et al. Genetic reversion via mitotic re‐
combination in ichthyosis with confetti due to a KRT10 polyalanine 
frameshift mutation. J Invest Dermatol. 2016;136(8):1725‐1728.
 11. Hotz A, Oji V, Bourrat E, et al. Erratum in: Expanding the clinical and 
genetic spectrum of KRT1, KRT2 and KRT10 mutations in keratino‐
pathic ichthyosis. Acta dermato‐venereologica. 2016;96:720.
 12. Fagerlund R, Melen K, Kinnunen L, Julkunen I. Arginine/lysine‐rich 
nuclear localization signals mediate interactions between dimeric 
STATs and importin alpha 5. J Biol Chem. 2002;277:30072‐30078.
 13. den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommenda‐
tions for the description of sequence variants: 2016 update. Hum 
Mutat. 2016;37:564‐569.
 14. Hotz A, Oji V, Bourrat E, et al. Expanding the Clinical and Genetic 
Spectrum of KRT1, KRT2 and KRT10 Mutations in Keratinopathic 
Ichthyosis. Acta dermato venereologica. 2016;96:473–478.
 15. Richardson ES, Lee JB, Hyde PH, Richard G. A novel mutation and 
large size polymorphism affecting the V2 domain of keratin 1 in an 
African‐American family with severe, diffuse palmoplantar ker‐
atoderma of the ichthyosis hystrix Curth‐Macklin type. J Invest 
Dermatol. 2006;126:79‐84.
 16. Sprecher E, Ishida‐Yamamoto A, Becker OM, et al. Evidence for 
novel functions of the keratin tail emerging from a mutation causing 
ichthyosis hystrix. J Invest Dermatol. 2001;116:511‐519.
 17. Whittock NV, Smith FJ, Wan H, et al. Frameshift mutation in the V2 
domain of human keratin 1 results in striate palmoplantar kerato‐
derma. J Invest Dermatol. 2002;118:838‐844.
 18. Aushev M, Koller U, Mussolino C, et al. Traceless targeting and 
isolation of gene‐edited immortalized keratinocytes from epi‐
dermolysis bullosa simplex patients. Mol Ther Methods Clin Dev. 
2017;6:112‐123.
8452  |     RENZ Et al.
 19. Chamcheu JC, Pihl‐Lundin I, Mouyobo CE, et al. Immortalized ke‐
ratinocytes derived from patients with epidermolytic ichthyosis re‐
produce the disease phenotype: a useful in vitro model for testing 
new treatments. Br J Dermatol. 2011;164:263‐272.
 20. Ran FA, Hsu PD, Wright J, et al. Genome engineering using the 
CRISPR‐Cas9 system. Nat Protoc. 2013;8:2281‐2308.
 21. March OP, Lettner T, Klausegger A, et al. Gene editing‐mediated 
disruption of epidermolytic ichthyosis‐associated KRT10 alleles 
restores filament stability in keratinocytes. J Invest Dermatol. 
2019;139(8):1699‐1710.e6.
 22. Burger B, Hershkovitz D, Indelman M, et al. Buschke‐Ollendorff 
syndrome in a three‐generation family: influence of a novel 
LEMD3 mutation to tropoelastin expression. Eur J Dermatol. 
2010;20:693‐697.
 23. Parada GE, Munita R, Cerda CA, Gysling K. A comprehensive survey 
of non‐canonical splice sites in the human transcriptome. Nucleic 
Acids Res. 2014;42:10564‐10578.
 24. Burge C, Karlin S. Prediction of complete gene structures in human 
genomic DNA. J Mol Biol. 1997;268:78‐94.
 25. Robertson HM. Noncanonical GA and GG 5′ intron donor splice 
sites are common in the copepod Eurytemora affinis. G3 (Bethesda). 
2017;7:3967‐3969.
 26. Sharp PA, Burge CB. Classification of introns: U2‐type or U12‐type. 
Cell. 1997;91:875‐879.
 27. Martin RM, Ter‐Avetisyan G, Herce HD, et al. Principles of protein 
targeting to the nucleolus. Nucleus. 2015;6:314‐325.
 28. Scott MS, Boisvert FM, McDowall MD, et al. Characterization and 
prediction of protein nucleolar localization sequences. Nucleic Acids 
Res. 2010;38:7388‐7399.
 29. Fonseca DJ, Rojas RF, Vergara JI, et al. A severe familial phenotype 
of Ichthyosis Curth‐Macklin caused by a novel mutation in the 
KRT1 gene. Br J Dermatol. 2013;168:456‐458.
 30. Marghescu S, Anton‐Lamprecht I, Rudolph PO, Kaste R. [Congenital 
reticular ichthyosiform erythroderma]. Der Hautarzt; Zeitschrift fur 
Dermatologie, Venerologie, und verwandte. Gebiete. 1984;35:522‐529.
 31. Elbaum DJ, Kurz G, MacDuff M. Increased incidence of cutane‐
ous carcinomas in patients with congenital ichthyosis. J Am Acad 
Dermatol. 1995;33:884‐886.
 32. Hendrix JD Jr, Patterson JW, Greer KE. Skin cancer associ‐
ated with ichthyosis: the MAUIE syndrome. J Am Acad Dermatol. 
1997;37:1000‐1002.
 33. Torrelo A, Marrero MD, Mediero IG, et al. Progressive macular leu‐
coderma in a patient with congenital ichthyosiform erythroderma. 
Br J Dermatol. 2001;144:1280‐1282.
 34. Krunic AL, Palcesky D, Busbey S, Medenica M. Congenital retic‐
ular ichthyosiform erythroderma–ichthyosis variegata: a case 
report and review of the literature. Acta dermato‐venereologica. 
2003;83:36‐39.
 35. Long MC. Ichthyosis with confetti: a rare diagnosis and treatment 
plan. BMJ Case Rep. 2014; 2014. https ://doi.org/10.1136/bcr20 
14204509
 36. Kalinska‐Bienias A, Pollak A, Kowalewski C, et al. Coexistence of 
mutations in keratin 10 (KRT10) and the mitochondrial genome in 
a patient with ichthyosis with confetti and Leber's hereditary optic 
neuropathy. Am J Med Genet A. 2017;173:3093‐3097.
 37. Nomura TS, Miyauchi T, Takeda M, et al. Chromosomal inver‐
sions as a hidden disease‐modifying factor. J Investig Dermatol. 
2017;137:S193‐S352.
 38. Pallesen K, Clemmensen O, Fischer J, et al. Ichthyosis with 
confetti inherited from a mosaic father. Acta Derm Venereol. 
2018;98:130‐131.
 39. Diociaiuti A, Fortugno P, El Hachem M, et al. Early immunopatho‐
logical diagnosis of ichthyosis with confetti in two sporadic cases 
with new mutations in keratin 10. Acta dermato‐venereologica. 
2014;94(5):579‐582.
 40. Saito R, Boyce A, Hsu CK, et al. Predictive phenotyping of inher‐
ited ichthyosis by next‐generation DNA sequencing. Br J Dermatol. 
2017;176:249‐251.
 41. Dvorakova V, Watson R, Terron‐Kwiatkowski A, et al. Congenital 
reticular ichthyosiform erythroderma. Clin Exp Dermatol. 
2016;41:576‐577.
 42. Foo SH, Terron‐Kwiatkowski A, Baty D, Browne F. Ichthyosis with 
confetti presenting as collodion baby: a novel mutation in KRT10. 
Clin Exp Dermatol. 2017;42:543‐544.
 43. Brusasco A, Tadini G, Cambiaghi S, et al. A case of congenital re‐
ticular ichthyosiform erythroderma–ichthyosis 'en confettis'. 
Dermatology (Basel, Switzerland). 1994;188:40‐45.
 44. Brusasco A, Cambiaghi S, Tadini G, et al. Unusual hyperpigmenta‐
tion developing in congenital reticular ichthyosiform erythroderma 
(ichthyosis variegata). Br J Dermatol. 1998;139:893‐896.
 45. Rufli T, Schneider BV, Schnyder UW. [Non‐bullous erythroderma 
(congenital) ichthyosiforme with perinuclear shells]. Der Hautarzt; 
Zeitschrift fur Dermatologie, Venerologie, und verwandte. Gebiete. 
1990;41:442‐447.
 46. Takeichi T, Liu L, Abdul‐Wahab A, et al. Large intragenic KRT1 dele‐
tion underlying atypical autosomal dominant keratinopathic ichthy‐
osis. J Invest Dermatol. 2016; 136: 2095‐2098.
 47. Sprecher E, Yosipovitch G, Bergman R, et al. Epidermolytic hyper‐
keratosis and epidermolysis bullosa simplex caused by frameshift 
mutations altering the v2 tail domains of keratin 1 and keratin 5. J 
Invest Dermatol. 2003;120:623‐626.
 48. Suzuki S, Nomura T, Miyauchi T, et al. Revertant mosaicism in 
ichthyosis with confetti caused by a novel frameshift mutation in 
KRT1. J Invest Dermatol. 2016; 136: 2093‐2095.
 49. Kubo Y, Urano Y, Matsuda R, et al. Ichthyosis hystrix, Curth‐Macklin 
type: a new sporadic case with a novel mutation of keratin 1. Arch 
Dermatol. 2011;147:999‐1001.
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting Information section.       
How to cite this article: Renz P, Imahorn E, Spoerri I, et al. 
Arginine‐ but not alanine‐rich carboxy‐termini trigger nuclear 
translocation of mutant keratin 10 in ichthyosis with confetti. J 
Cell Mol Med. 2019;23:8442–8452. https ://doi.org/10.1111/
jcmm.14727 
